Minas Gerais Receives Over R$185 Million in 2026 Boost to Scientific Infrastructure and Vaccine Research

Minas Gerais is experiencing a significant bolstering of its scientific infrastructure in 2026, fueled by coordinated investments unveiled by the federal Ministry of Science, Technology, and Innovation (MCTI) and state partners. On March 16, the Ministry announced a landmark allocation of R$105 million aimed at enhancing research laboratories and expanding infrastructure at federal universities across the state. This funding package, comprising 19 agreements, focuses on modernizing scientific equipment, maintaining laboratory infrastructure, and creating new research centers with priority in fields such as health, biotechnology, precision medicine, energy, biodiversity, and the environment.

Highlighting the scale of federal support, Minister Luciana Santos emphasized that Minas Gerais has seen a 74% increase in science funding since 2023, with total investment reaching R$3.3 billion compared to R$1.9 billion between 2019-2022. "These investments are essential for universities to produce cutting-edge science, train highly qualified professionals, and create technologies addressing national challenges," Santos said.

The day coincided with the 10th anniversary celebration of the Vaccine Technology Center (CTVacinas) at the Federal University of Minas Gerais (UFMG) and the important delivery of the first phase of the National Vaccine Center (CNVacinas) facility in Belo Horizonte. The CNVacinas, backed by a R$80 million investment split between the National Fund for Scientific and Technological Development (FNDCT) and the Minas Gerais government, aims to revolutionize vaccine development, production of diagnostic kits, and pharmaceutical innovation. Its phased construction will complete by late 2027 and is expected to enhance Brazil's autonomy in vaccine manufacturing—a critical need underscored by the Covid-19 pandemic.

Minister Santos highlighted CNVacinas as a pivotal integration of research, development, and pilot vaccine production, facilitating technology transfer and contributing directly to public health solutions. The center represents a major step towards scientific sovereignty and rapid response capability to health emergencies.

Together, these initiatives reflect a sustained strategic investment in Minas Gerais' scientific capabilities, positioning the state as a leader in national scientific innovation and public health. The coupling of expanded infrastructure funding with key projects such as CNVacinas underscores Brazil’s commitment to advancing science and technology to meet both current and future challenges.